Correlation Between Circulating PCSK9 Levels and Gestational Diabetes Mellitus in a Chinese Population
出版年份 2022 全文链接
标题
Correlation Between Circulating PCSK9 Levels and Gestational Diabetes Mellitus in a Chinese Population
作者
关键词
-
出版物
Frontiers in Endocrinology
Volume 13, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2022-04-13
DOI
10.3389/fendo.2022.826757
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Novel Therapeutical Approaches to Managing Atherosclerotic Risk
- (2021) Rosaria Vincenza Giglio et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Inclisiran: a small interfering RNA strategy targeting PCSK9 to treat hypercholesterolemia
- (2021) Yajnavalka Banerjee et al. Expert Opinion On Drug Safety
- Research progress on alternative non-classical mechanisms of PCSK9 in atherosclerosis in patients with and without diabetes
- (2020) Ying Tang et al. Cardiovascular Diabetology
- Progression to type 2 diabetes in women with a known history of gestational diabetes: systematic review and meta-analysis
- (2020) Elpida Vounzoulaki et al. BMJ-British Medical Journal
- Elevated galectin-3 in women with gestational diabetes mellitus, a new surrogate for cardiovascular disease in women
- (2020) Yeela Talmor-Barkan et al. PLoS One
- Association of circulating proprotein convertase subtilisin/kexin type 9 levels and the risk of incident type 2 diabetes in subjects with prediabetes: a population-based cohort study
- (2020) Jie Shi et al. Cardiovascular Diabetology
- 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2021
- (2020) DIABETES CARE
- Hyperglycemia and Adverse Pregnancy Outcome Follow-up Study (HAPO FUS): Maternal Gestational Diabetes and Childhood Glucose Metabolism
- (2019) William L. Lowe et al. DIABETES CARE
- Future perspectives of the pharmacological management of diabetic dyslipidemia
- (2019) Angelo Maria Patti et al. Expert Review of Clinical Pharmacology
- Association of serum proprotein convertase subtilisin/kexin type 9 with early atherosclerosis in newly diagnosed type 2 diabetes mellitus
- (2019) Wen Guo et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- PCSK9 deficiency reduces insulin secretion and promotes glucose intolerance: the role of the low-density lipoprotein receptor
- (2018) Lorenzo Da Dalt et al. EUROPEAN HEART JOURNAL
- Circulating PCSK9 levels and 2-hPG are positively correlated in metabolic diseases in a Chinese Han population
- (2018) Wen Guo et al. Lipids in Health and Disease
- Prevalence of Gestational Diabetes Mellitus in Eastern and Southeastern Asia: A Systematic Review and Meta-Analysis
- (2018) Cong Luat Nguyen et al. Journal of Diabetes Research
- Association between proprotein convertase subtilisin/kexin 9 (PCSK9) and lipoprotein subclasses in children with type 1 diabetes mellitus: Effects of glycemic control
- (2018) Dragana Bojanin et al. ATHEROSCLEROSIS
- Obesity and type 2 diabetes are associated with elevated PCSK9 levels in young women
- (2017) Amy E. Levenson et al. PEDIATRIC DIABETES
- Modulation of cholesterol transport by maternal hypercholesterolemia in human full-term placenta
- (2017) Ran Zhang et al. PLoS One
- Targeting PCSK9 for therapeutic gains: Have we addressed all the concerns?
- (2016) Yajnavalka Banerjee et al. ATHEROSCLEROSIS
- Role of Insulin in the Regulation of Proprotein Convertase Subtilisin/Kexin Type 9Significance
- (2015) Ji Miao et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Positive correlation of plasma PCSK9 levels with HbA1cin patients with type 2 diabetes
- (2015) Sheng-Hua Yang et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Plasma proprotein convertase subtilisin/kexin type 9 is associated with Lp(a) in type 2 diabetic patients
- (2015) Ymène Nekaies et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- Association of plasma PCSK9 levels with white blood cell count and its subsets in patients with stable coronary artery disease
- (2014) Sha Li et al. ATHEROSCLEROSIS
- PCSK9 Inhibition - A Novel Mechanism to Treat Lipid Disorders?
- (2013) Maciej Banach et al. CURRENT PHARMACEUTICAL DESIGN
- Diagnosis of Gestational Diabetes Mellitus in China
- (2013) W.-w. Zhu et al. DIABETES CARE
- Trying to understand gestational diabetes
- (2013) P. M. Catalano DIABETIC MEDICINE
- Plasma proprotein convertase subtilisin kexin type 9 is not altered in subjects with impaired glucose metabolism and type 2 diabetes mellitus, but its relationship with non-HDL cholesterol and apolipoprotein B may be modified by type 2 diabetes mellitus: The CODAM study
- (2011) M.C.G.J. Brouwers et al. ATHEROSCLEROSIS
- Association between plasma PCSK9 and gamma-glutamyl transferase levels in diabetic patients
- (2010) Bertrand Cariou et al. ATHEROSCLEROSIS
- Serum PCSK9 is associated with multiple metabolic factors in a large Han Chinese population
- (2010) Qin Cui et al. ATHEROSCLEROSIS
- International Association of Diabetes and Pregnancy Study Groups Recommendations on the Diagnosis and Classification of Hyperglycemia in Pregnancy
- (2010) DIABETES CARE
- Plasma PCSK9 Is Associated with Age, Sex, and Multiple Metabolic Markers in a Population-Based Sample of Children and Adolescents
- (2009) A. Baass et al. CLINICAL CHEMISTRY
- Genetic and Metabolic Determinants of Plasma PCSK9 Levels
- (2009) Susan G. Lakoski et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now